Works matching IS 2160763X AND DT 2022 AND VI 11 AND IP 12

Results: 14

Issue Information.
Published in:
Clinical Pharmacology in Drug Development, 2022, v. 11, n. 12, p. 1357, doi. 10.1002/cpdd.834
Publication type:
Article
Authorship.
Published in:
Clinical Pharmacology in Drug Development, 2022, v. 11, n. 12, p. 1362, doi. 10.1002/cpdd.1190
By:
- Greenblatt, David J.
Publication type:
Article
Challenges in the Development of Intravenous Neurokinin‐1 Receptor Antagonists: Results of a Safety and Pharmacokinetics Dose‐Finding, Phase 1 Study of Intravenous Fosnetupitant.
Published in:
Clinical Pharmacology in Drug Development, 2022, v. 11, n. 12, p. 1405, doi. 10.1002/cpdd.1183
By:
- Tyler, Timothy;
- Schultz, Armin;
- Venturini, Alessio;
- Giuliano, Claudio;
- Bernareggi, Alberto;
- Spezia, Riccardo;
- Voisin, Daniel;
- Stella, Valentino
Publication type:
Article
Safety, Pharmacokinetics, and Pharmacodynamics of CC‐90001 (BMS‐986360), a c‐Jun N‐terminal Kinase Inhibitor, in Phase 1 Studies in Healthy Participants.
Published in:
Clinical Pharmacology in Drug Development, 2022, v. 11, n. 12, p. 1394, doi. 10.1002/cpdd.1178
By:
- Ye, Ying;
- Gaudy, Allison;
- Thomas, Michael;
- Reyes, Josephine;
- Burkhardt, Barbara;
- Horan, Gerald;
- Liu, Liangang;
- Chen, Jian;
- Ghosh, Atalanta;
- Carayannopoulos, Leonidas N.;
- Tatosian, Daniel A.;
- Palmisano, Maria
Publication type:
Article
Safety, Tolerability, and Pharmacokinetics of Intravenous Doses of PF‐07304814, a Phosphate Prodrug Protease Inhibitor for the Treatment of SARS‐CoV‐2, in Healthy Adult Participants.
Published in:
Clinical Pharmacology in Drug Development, 2022, v. 11, n. 12, p. 1382, doi. 10.1002/cpdd.1174
By:
- Zhu, Tong;
- Pawlak, Sylvester;
- Toussi, Sima S.;
- Hackman, Frances;
- Thompson, Kimberly;
- Song, Wei;
- Salageanu, Joanne;
- Winter, Erica;
- Shi, Haihong;
- Winton, Jennifer;
- Binks, Michael
Publication type:
Article
Bioequivalence and Pharmacokinetic Study of 2 Edoxaban Tablets in Healthy Chinese Subjects.
Published in:
Clinical Pharmacology in Drug Development, 2022, v. 11, n. 12, p. 1440, doi. 10.1002/cpdd.1156
By:
- Liu, Lihua;
- Li, Xin;
- Liu, Yujie;
- Xu, Bing;
- Li, Yuan;
- Yuan, Fang;
- Zhang, Ping;
- Tu, Shengqing;
- Hu, Wenhui
Publication type:
Article
Population Pharmacokinetics of Oral Brepocitinib in Healthy Volunteers and Patients.
Published in:
Clinical Pharmacology in Drug Development, 2022, v. 11, n. 12, p. 1447, doi. 10.1002/cpdd.1163
By:
- Hughes, Jim H.;
- Qiu, Ruolun;
- Banfield, Christopher;
- Dowty, Martin E.;
- Nicholas, Timothy
Publication type:
Article
Population Pharmacokinetics of Oral Migalastat in Adolescents and Adults With and Without Renal Impairment.
Published in:
Clinical Pharmacology in Drug Development, 2022, v. 11, n. 12, p. 1367, doi. 10.1002/cpdd.1160
By:
- Leonowens, Cathrine;
- Schmith, Virginia;
- Zhou, Jie;
- Wu, Yi Shuan;
- Ivaturi, Vijay;
- Johnson, Franklin K.
Publication type:
Article
Pharmacokinetic and Bioequivalence Study of Eldecalcitol Soft Capsules in Healthy Chinese Subjects.
Published in:
Clinical Pharmacology in Drug Development, 2022, v. 11, n. 12, p. 1474, doi. 10.1002/cpdd.1159
By:
- Li, Ting;
- Sun, Feifei;
- Liu, Yanping;
- Su, Lingping;
- Shi, Ping;
- Li, Xin;
- Liu, Shuqin;
- Wang, Chenjing;
- Shen, Linjing;
- Cao, Yu;
- Wang, Shumin
Publication type:
Article
Bioequivalence of China‐ and Germany‐Manufactured Metformin Extended‐Release Tablets Under Fed and Fasted Conditions in Healthy Volunteers: A Randomized, Open‐Label, 2‐Way Crossover Study.
Published in:
Clinical Pharmacology in Drug Development, 2022, v. 11, n. 12, p. 1430, doi. 10.1002/cpdd.1158
By:
- Hu, Chaoying;
- Pei, Tong;
- Li, Dandan;
- Zhou, Dongli;
- Zhang, Lan
Publication type:
Article
Drug‐Drug Interactions With the Hepatitis B Virus Capsid Assembly Modulator JNJ‐56136379 (Bersacapavir).
Published in:
Clinical Pharmacology in Drug Development, 2022, v. 11, n. 12, p. 1419, doi. 10.1002/cpdd.1164
By:
- Vandenbossche, Joris;
- Yogaratnam, Jeysen;
- Hillewaert, Vera;
- Rasschaert, Freya;
- Talloen, Willem;
- Biewenga, Jeike;
- Snoeys, Jan;
- Kakuda, Thomas N.;
- Palmer, Martyn;
- Nangosyah, Julius;
- Biermer, Michael
Publication type:
Article
Bioequivalence of Two Linezolid Tablets Under Fed and Fasting Conditions in Healthy Chinese Individuals.
Published in:
Clinical Pharmacology in Drug Development, 2022, v. 11, n. 12, p. 1481, doi. 10.1002/cpdd.1155
By:
- Wang, Shumin;
- Guo, Shaojie;
- Han, Ying;
- Ni, Siyang;
- Wu, Feng;
- Dai, Yuyang;
- Xia, Qiang;
- Yang, Yan;
- Zhao, Xiuli
Publication type:
Article
PKPD Modeling and Simulations to Support Biosimilar Development of Biphasic Insulin Aspart 30.
Published in:
Clinical Pharmacology in Drug Development, 2022, v. 11, n. 12, p. 1457, doi. 10.1002/cpdd.1152
By:
- Petrov, Aleksandr V.;
- Zinnatulina, Bella R.;
- Drai, Roman V.;
- Karonova, Tatiana L.;
- Koksharova, Ekaterina O.;
- Dorotenko, Artem R.;
- Makarenko, Igor E.
Publication type:
Article
Pharmacokinetics and Safety Study of HN0037, a Novel Anti‐Human Herpes Simplex Virus Inhibitor, in Healthy Volunteers.
Published in:
Clinical Pharmacology in Drug Development, 2022, v. 11, n. 12, p. 1467, doi. 10.1002/cpdd.1138
By:
- Hou, Jie;
- Gao, Hong;
- Fan, Yingzhe;
- Wang, Ying;
- Qin, Meng;
- Di, Yujing;
- Wang, Lu;
- Zhou, Xin;
- Zhou, Yi;
- Qin, Donghui;
- Hill, George
Publication type:
Article